Qilian International Holding Group (Qilian International Holding Group) Price-to-Owner-Earnings : (As of May. 21, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group Price-to-Owner-Earnings?

As of today (2024-05-21), Qilian International Holding Group's share price is $0.661. Qilian International Holding Group does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.

The historical rank and industry rank for Qilian International Holding Group's Price-to-Owner-Earnings or its related term are showing as below:

During the past 7 years, the highest Price-to-Owner-Earnings of Qilian International Holding Group was 6.01. The lowest was 2.63. And the median was 3.81.

QLI's Price-to-Owner-Earnings is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 28.05
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-21), Qilian International Holding Group's share price is $0.661. Qilian International Holding Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.22. Therefore, Qilian International Holding Group's PE Ratio for today is At Loss.

As of today (2024-05-21), Qilian International Holding Group's share price is $0.661. Qilian International Holding Group's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.06. Therefore, Qilian International Holding Group's PE Ratio without NRI for today is At Loss.

During the past 7 years, Qilian International Holding Group's highest PE Ratio without NRI was 61.19. The lowest was 0.00. And the median was 25.06.

Qilian International Holding Group Price-to-Owner-Earnings Historical Data

The historical data trend for Qilian International Holding Group's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qilian International Holding Group Price-to-Owner-Earnings Chart

Qilian International Holding Group Annual Data

Trend

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Price-to-Owner-Earnings

Get a 7-Day Free Trial

4.23

Qilian International Holding Group Semi-Annual Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Price-to-Owner-Earnings	Get a 7-Day Free Trial								-	-	4.23	-	-

Competitive Comparison of Qilian International Holding Group's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Qilian International Holding Group's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qilian International Holding Group's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qilian International Holding Group's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Qilian International Holding Group's Price-to-Owner-Earnings falls into.

Qilian International Holding Group Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Qilian International Holding Group's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	0.661	/	-0.20
	=

Qilian International Holding Group (NAS:QLI) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

Qilian International Holding Group Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

Qilian International Holding Group (Qilian International Holding Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » Price-to-Owner-Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000

Website

http://ir.qlsyy.net

Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.